Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2003 by Alexion Pharmaceuticals. Recruitment status was Active, not recruiting
Study NCT00048308
Information provided by Alexion Pharmaceuticals
First Received on October 29, 2002.
Last Updated on September 13, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
